NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
Mulvaney, Eamon P., Reid, Helen M., Bialesova, Lucia, Bouchard, Annie, Salvail, Dany, Kinsella, B. ThereseVolume:
20
Journal:
BMC Pulmonary Medicine
DOI:
10.1186/s12890-020-1113-2
Date:
December, 2020
File:
PDF, 16.12 MB
2020